Seer Inc
SEER.OQ- Latest Trade
- trading lower7.76USD
- Change
- -0.56
- % Change
6.73%Negative
- Day Range
- 7.75 - 8.39
- 52-Week Range
- 6.84 - 45.84
As of May 18 2022. Values delayed up to 15 minutes
- Previous Close
- 8.32
- Open
- 7.98
- Volume
- 44,214.00
- 3 Month Average Trading Volume
- 8.21
- Shares Out (Mil)
- 62.44
- Market Cap
- 536.38
- Forward P/E
- -5.42
- Dividend Yield
- -99,999.99
Key Statistics
2.5 mean rating - 4 analysts
- P/E Excl. Extra Items (TTM)
- -99,999.99
- Price To Sales (TTM)
- 54.36
- Price To Book (Quarterly)
- 1.10
- Price To Cash Flow (Per Share TTM)
- -99,999.99
- Total Debt/Total Equity (Quarterly)
- 0.00
- Long Term Debt/Equity (Quarterly)
- 0.00
- Return On Investment (TTM)
- -14.87
- Return On Equity (TTM)
- -14.61
2021 (millions USD)
About Seer Inc
Company Information
Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products. The Company’s initial product, the Proteograph product suite leverages its engineered nanoparticle (NP) technology to provide large-scale access to the proteome. The Proteograph product suite is an integrated solution that is comprised of consumables, an automation instrument, and software. Its approach is based on engineered NPs that enable unbiased sampling of intact proteins across the dynamic range of the proteome, capturing a myriad of molecular information at the level of protein variants as well as protein-protein interactions (PPIs). It is focused on adoption of the Proteograph with customers in the proteomics and genomics markets. The Company is initially focused on research applications for the Proteograph product Suite and are selling and marketing the Proteograph for research use only (RUO) eliminates the need for complex workflows required by other unbiased approaches.
Address
3800 Bridge Parkway, Suite 102REDWOOD CITY, CA
94065
United States
Industry
Scientific & Technical Instr.
Executive Leadership
- Omid C. Farokhzad
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Omead Ostadan
- President
- David R. Horn
- Chief Financial Officer
- Scott Thomas
- Chief Commercial Officer
- David L. Hallal
- Lead Independent Director
- Rachel E. Haurwitz
- Director
- Robert S. Langer
- Director
- Mostafa Ronaghi
- Director
- Catherine J. Friedman
- Independent Director
- Meeta Gulyani
- Independent Director
- Terrance G. McGuire
- Independent Director
- Dipchand V. Nishar
- Independent Director
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,819.70 | 0.08%Positive |
| Copper | 755.80 | 1.28%Negative |
| Brent Crude Oil | 109.02 | 2.60%Negative |
| CBOT Soybeans | 1,664.00 | 0.83%Negative |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,914.78 | 4.26%Negative |
| Euro STOXX 50 | 3,690.74 | 1.36%Negative |
| FTSE 100 | 7,438.09 | 1.07%Negative |
| Nikkei 225 | 26,911.20 | 0.94%Positive |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes